Evidence map›Paper›PMID 35565242›Full record

ArticleCancers2022

Glycolysis Dependency as a Hallmark of

Raquel Vivet-Noguer, Malcy Tarin, Christine Canbezdi, Stephane Dayot, Lisseth Silva, Alexandre Houy, Sylvain Martineau, Virginie Mieulet, Géraldine Gentric, Damarys Loew and 9 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. The Impact of Spliceosome Inhibition in SF3B1-Mutated Uveal Melanoma.Investigative ophthalmology & visual science · 2024
    Article
  6. Science advances · 2024
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Raquel Vivet-NoguerTranslational Research Department, Institut Curie, PSL Research University, 75248 Paris, France.ORCID 0000-0001-9290-1428
Malcy TarinTranslational Research Department, Institut Curie, PSL Research University, 75248 Paris, France.ORCID 0000-0002-3865-9631
Christine CanbezdiTranslational Research Department, Institut Curie, PSL Research University, 75248 Paris, France.ORCID 0000-0002-9846-3921
Stephane DayotINSERM U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Equipe labellisée par la Ligue Nationale Contre le Cancer, Institut Curie, PSL Research University, 75248 Paris, France.
Lisseth SilvaTranslational Research Department, Institut Curie, PSL Research University, 75248 Paris, France.
Alexandre HouyINSERM U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Equipe labellisée par la Ligue Nationale Contre le Cancer, Institut Curie, PSL Research University, 75248 Paris, France.ORCID 0000-0001-6267-2353
Sylvain MartineauCNRS UMR3348, INSERM U1278, Institut Curie, PSL Research University, 75248 Paris, France.
Virginie MieuletINSERM U830, Stress and Cancer Laboratory, Equipe labellisée par la Ligue Nationale Contre le Cancer, Institut Curie, PSL Research University, 75248 Paris, France.
Géraldine GentricINSERM U830, Stress and Cancer Laboratory, Equipe labellisée par la Ligue Nationale Contre le Cancer, Institut Curie, PSL Research University, 75248 Paris, France.ORCID 0000-0002-7558-8705
Damarys LoewMass Spectrometry and Proteomics Facility, Institut Curie, PSL Research University, 75248 Paris, France.ORCID 0000-0002-9111-8842
Bérangère LombardMass Spectrometry and Proteomics Facility, Institut Curie, PSL Research University, 75248 Paris, France.
Fariba NematiTranslational Research Department, Institut Curie, PSL Research University, 75248 Paris, France.ORCID 0000-0001-8879-7592
Sophie RichonCNRS UMR 144, Institut Curie, PSL Research University, 75248 Paris, France.
Lea GuyonnetCytometry Core, Institut Curie, PSL Research University, 75248 Paris, France.
Vincent ServoisDepartment of Radiology, Institut Curie, PSL Research University, 75248 Paris, France.ORCID 0000-0002-8378-8432
Stephan VagnerCNRS UMR3348, INSERM U1278, Institut Curie, PSL Research University, 75248 Paris, France.ORCID 0000-0003-1452-7164
Marc-Henri SternINSERM U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Equipe labellisée par la Ligue Nationale Contre le Cancer, Institut Curie, PSL Research University, 75248 Paris, France.ORCID 0000-0002-8100-2272
Sergio Roman-RomanTranslational Research Department, Institut Curie, PSL Research University, 75248 Paris, France.
Samar AlsafadiTranslational Research Department, Institut Curie, PSL Research University, 75248 Paris, France.ORCID 0000-0002-0060-1346
Université Paris Sciences et Lettres · FRInserm · FRCentre National de la Recherche Scientifique · FR

Funding

European Union's Horizon 2020 project "UM Cure 2020" Grant No 667787European Union's Horizon 2020 research and innovation programme Marie Skłodowska-Curie grant agreement No 666003Ligue Nationale Contre le Cancer Grant No 20117 and group labellisationSIRIC Curie Grant INCa-DGOS-Inserm_12554
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

glycolysismetabolismSF3B1splicinguveal melanoma

Identifiers

PMID35565242
PMCPMC9101609
OpenAlexW4224323957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.